Clinical Trials
- Phase 1 Cancers
test
- Phase 1 Cancers
Phase 1b/2 Study of ATR InhibiTor RP-3500 and PARP Inhibitor Combinations in Patients With Molecularly Selected Cancers (ATTACC)
- Head and Neck Cancers
test
- Head and Neck Cancers
Single-Arm Phase II Trial of Dual Inhibition of EGFR With Afatinib and Cetuximab With Correlative Studies in the Second-Line Treatment of Recurrent or Metastatic Squamous Cell Cancers of the Head and Neck
- Ages18 years and older
- GenderBoth
- Prostate Cancer, Phase 1 Cancers
test
- Ages18 years and older
- GenderMale only
- Phase 1 Cancers
test
- Lung Cancer, Phase 1 Cancers
test
- Lung Cancer
test
- Sarcoma Cancers, Kidney Cancer, Pediatric Cancers
Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumors
- Phase 1 Cancers
test